Discover 649 paid clinical trials in Charleston, South Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 649
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
for
Type 2 Diabetes, Cortisol Excess
Location: Mt. Pleasant SC, Wilmington NC, Anderson SC,
Sponsor: Sparrow Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07296484
Phase2, Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
for
Overweight, Obesity
Location: Mt. Pleasant SC, Wilmington NC, Jacksonville FL,
Get alerts for new trials in your area by subscribing now
FebriDx® Pediatric Validation Study
for
Acute Respiratory Infections (ARIs)
Location: Charleston SC, Lutz FL, Tampa FL, Clearwater FL,
Sponsor: Lumos Diagnostics
Sex: All
Age: 2 - 11
Code: NCT07211997
Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
An Observational Study of Individuals With Isolated Dystonia
for
Isolated/Primary Dystonia That Affects More Than One Region of the Body,
Location: Charleston SC, New York NY, Chicago IL, Houston TX,
Sponsor: Vima Therapeutics
Sex: All
Age: 12 - 65
Code: NCT07111663
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
for
Refractory Rheumatoid Arthritis (RA),
Location: Charleston SC, Charlotte NC, Statesville NC,
Sponsor: Artiva Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06991114
Phase2, Recruiting
New
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
for
Hidradenitis Suppurativa
Location: Charleston SC, New Albany IN, Boardman OH,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07665437
Phase3, Recruiting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
for
Cutaneous Squamous Cell Carcinoma (CSCC)
Location: Charleston SC, Chapel Hill NC, Tampa FL, Richmond VA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06585410
Phase3, Recruiting
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM